£107.98

Springer Targeting the Wnt Pathway in Cancer

Price data last checked 36 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£108 today · cheaper than every other day in the last 2 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 28 days • 28 data points (No recent data available)

Historical
Generating forecast...
£107.98 £102.58 £104.74 £106.90 £109.06 £111.22 £113.38 02 May 2026 08 May 2026 15 May 2026 22 May 2026 29 May 2026

Price Distribution

Price distribution over 28 days • 1 price levels

Days at Price
28 days 0 7 14 21 28 £108 Days at Price

Price Analysis

Most common price: £108 (28 days, 100.0%)

Price range: £108 - £108

Price levels: 1 different prices over 28 days

Description

Inappropriate activation of the Wnt signaling pathway is observed in many human cancers and is sufficient to drive tumor initiation and progression in numerous contexts. Multiple mechanisms, such as overexpression of Wnt ligands, inactivation of the APC and Axin tumor suppressors, and mutation of -catenin, are responsible for pathway activation in tumor cells. The development of potent Wnt pathway antagonists for therapeutic use has been a major effort for investigators in both academia and industry in recent years. This book will provide an overview of the Wnt pathway as a therapeutic target for cancer, and discuss the preclinical development of inhibitors specifically directed to upstream and downstream components of the pathway.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
13 October 2014
Listed Since
14 October 2014

Barcode

No barcode data available

Similar Products You Might Like

Cell Signaling & Molecular Targets in Cancer
85% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 14 May 2026
Cell Signaling & Molecular Targets in Cancer
85% match

Cell Signaling & Molecular Targets in Cancer

Springer

£43.99 19 May 2026
Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach
85% match

Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach

Springer

£74.35 06 Jun 2026
Signaling Pathways and Molecular Mediators in Metastasis
84% match

Signaling Pathways and Molecular Mediators in Metastasis

Springer

£113.76 22 Jun 2026
Regulation of Carcinogenesis, Angiogenesis and Metastasis by the Proprotein Convertases (PC's): A New Potential Strategy in Cancer Therapy
84% match

Regulation of Carcinogenesis, Angiogenesis and Metastasis by the Proprotein Convertases (PC's): A New Potential Strategy in Cancer Therapy

Springer

£113.76 09 Jun 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
83% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 24 May 2026
Wnt Signaling: Methods and Protocols: 1481 (Methods in Molecular Biology, 1481)
83% match

Wnt Signaling: Methods and Protocols: 1481 (Methods in Molecular Biology, 1481)

Humana

£73.10 12 Jun 2026
Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance
83% match

Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance

Academic Press

£145.99 21 May 2026
Molecular Pathogenesis of Colorectal Cancer
83% match

Molecular Pathogenesis of Colorectal Cancer

Springer

£107.98 28 May 2026
Hedgehog signaling activation in human cancer and its clinical implications
83% match

Hedgehog signaling activation in human cancer and its clinical implications

Springer

£107.98 06 Jun 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
83% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 05 Jun 2026
Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)
83% match

Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)

Springer

£113.77 17 May 2026
Nutraceuticals and Cancer
83% match

Nutraceuticals and Cancer

Springer

£113.76 25 May 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
82% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£179.99 31 May 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
82% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£73.10 31 May 2026
Wnt Signaling: Volume 1: Pathway Methods and Mammalian Models: 468 (Methods in Molecular Biology, 468)
82% match

Wnt Signaling: Volume 1: Pathway Methods and Mammalian Models: 468 (Methods in Molecular Biology, 468)

Humana

£77.33 31 May 2026
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
82% match

Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)

Springer

£74.57 31 May 2026
Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)
82% match

Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)

Humana

£107.57 26 May 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
82% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£74.87 24 May 2026
The Hippo Signaling Pathway and Cancer
82% match

The Hippo Signaling Pathway and Cancer

Springer

£107.98 04 Jun 2026
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
82% match

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£107.98 06 Jun 2026
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
82% match

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£107.98 24 May 2026
The Rho GTPases in Cancer
82% match

The Rho GTPases in Cancer

Springer

£107.98 03 Jun 2026
Angiogenesis and Anti-Angiogenesis in Hematological Malignancies
82% match

Angiogenesis and Anti-Angiogenesis in Hematological Malignancies

Springer

£88.40 04 Jun 2026